Takeda Pharmaceutical Co Ltd SEC filings TAK

Takeda Pharmaceutical Co Ltd has 709 filings in SEC EDGAR's recent list, going back to Mar 5, 2007. Its latest annual report, Form 20-F, was filed on Jun 17, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 29, 2026.

Takeda Pharmaceutical Co Ltd SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
6-K Current report (foreign issuer) Oct 29, 2026 Oct 29, 2026
6-K Current report (foreign issuer) Oct 29, 2026 Oct 29, 2026
4 Insider transaction Sep 15, 2026 Sep 14, 2026
6-K Current report (foreign issuer) Sep 14, 2026 Sep 14, 2026
144 Notice of proposed sale Sep 10, 2026 —
4 Insider transaction Sep 3, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 2, 2026 —
6-K Current report (foreign issuer) Aug 31, 2026 Aug 28, 2026
4 Insider transaction Aug 21, 2026 Aug 19, 2026
4 Insider transaction Aug 19, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 11, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 6, 2026 —
6-K Current report (foreign issuer) Aug 6, 2026 Aug 5, 2026
6-K Current report (foreign issuer) Jul 30, 2026 Jul 30, 2026
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
144 Notice of proposed sale Jul 13, 2026 —
6-K Current report (foreign issuer) Jul 9, 2026 Jul 9, 2026
6-K Current report (foreign issuer) Jul 8, 2026 Jul 8, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
3 Initial insider ownership Jul 6, 2026 Jun 24, 2026
3 Initial insider ownership Jul 6, 2026 Jun 24, 2026
3 Initial insider ownership Jul 6, 2026 Jun 24, 2026
6-K Current report (foreign issuer) Jun 29, 2026 Jun 29, 2026
6-K Current report (foreign issuer) Jun 26, 2026 Jun 26, 2026
6-K Current report (foreign issuer) Jun 24, 2026 Jun 24, 2026
6-K Current report (foreign issuer) Jun 24, 2026 Jun 24, 2026
6-K Current report (foreign issuer) Jun 24, 2026 Jun 24, 2026
IRANNOTICE Filing Jun 17, 2026 —
20-F Annual report (foreign issuer) Jun 17, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Jun 9, 2026 Jun 9, 2026
6-K Current report (foreign issuer) Jun 5, 2026 Jun 5, 2026
6-K Current report (foreign issuer) Jun 5, 2026 Jun 5, 2026
6-K Current report (foreign issuer) Jun 1, 2026 Jun 1, 2026
6-K Current report (foreign issuer) May 26, 2026 May 26, 2026
6-K Current report (foreign issuer) May 26, 2026 May 26, 2026
6-K Current report (foreign issuer) May 26, 2026 May 26, 2026
6-K Current report (foreign issuer) May 26, 2026 May 26, 2026
6-K Current report (foreign issuer) May 26, 2026 May 26, 2026
SD Specialized disclosure (conflict minerals) May 22, 2026 —
6-K Current report (foreign issuer) May 19, 2026 May 19, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
3 Initial insider ownership May 5, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
4 Insider transaction Apr 28, 2026 Apr 27, 2026
3 Initial insider ownership Apr 6, 2026 Apr 1, 2026
3 Initial insider ownership Apr 6, 2026 Apr 1, 2026
3 Initial insider ownership Apr 6, 2026 Apr 1, 2026
6-K Current report (foreign issuer) Mar 30, 2026 Mar 30, 2026
6-K Current report (foreign issuer) Mar 26, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 25, 2026 Mar 25, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Mar 2, 2026 Mar 2, 2026
6-K Current report (foreign issuer) Feb 10, 2026 Feb 10, 2026
6-K Current report (foreign issuer) Jan 29, 2026 Jan 29, 2026
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
4 Insider transaction Dec 9, 2025 Dec 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 9, 2025 —
144 Notice of proposed sale Dec 9, 2025 —
6-K Current report (foreign issuer) Dec 8, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 5, 2025 —
144 Notice of proposed sale Dec 4, 2025 —
6-K Current report (foreign issuer) Nov 28, 2025 Nov 28, 2025
13F-HR Filing Nov 13, 2025 Sep 30, 2025
6-K Current report (foreign issuer) Oct 30, 2025 Oct 30, 2025
6-K Current report (foreign issuer) Oct 30, 2025 Oct 30, 2025
6-K Current report (foreign issuer) Oct 30, 2025 Oct 30, 2025
6-K Current report (foreign issuer) Oct 1, 2025 Oct 1, 2025
6-K Current report (foreign issuer) Sep 25, 2025 Sep 25, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 19, 2025 —
6-K Current report (foreign issuer) Sep 8, 2025 Sep 8, 2025
N-PX Filing Aug 21, 2025 Aug 20, 2025
13F-HR Filing Aug 8, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jul 31, 2025 Jul 31, 2025
6-K Current report (foreign issuer) Jul 30, 2025 Jul 30, 2025
6-K Current report (foreign issuer) Jul 14, 2025 Jul 14, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
6-K Current report (foreign issuer) Jul 9, 2025 Jul 9, 2025
6-K Current report (foreign issuer) Jul 8, 2025 Jul 8, 2025
6-K Current report (foreign issuer) Jul 2, 2025 Jul 2, 2025
6-K Current report (foreign issuer) Jul 1, 2025 Jul 1, 2025
6-K Current report (foreign issuer) Jun 30, 2025 Jun 30, 2025
424B2 Prospectus Jun 27, 2025 —
FWP Free writing prospectus Jun 27, 2025 —
424B5 Prospectus supplement Jun 26, 2025 —
F-3ASR Filing Jun 25, 2025 —
20-F Annual report (foreign issuer) Jun 25, 2025 Mar 31, 2025
6-K Current report (foreign issuer) Jun 25, 2025 Jun 25, 2025
6-K Current report (foreign issuer) Jun 25, 2025 Jun 25, 2025
6-K Current report (foreign issuer) Jun 12, 2025 Jun 12, 2025
6-K Current report (foreign issuer) Jun 10, 2025 Jun 10, 2025
6-K Current report (foreign issuer) Jun 6, 2025 Jun 6, 2025
6-K Current report (foreign issuer) Jun 2, 2025 Jun 2, 2025
6-K Current report (foreign issuer) Jun 2, 2025 Jun 2, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) May 14, 2025 May 14, 2025
SD Specialized disclosure (conflict minerals) May 12, 2025 —
13F-HR Filing May 12, 2025 Mar 31, 2025
6-K Current report (foreign issuer) May 8, 2025 May 8, 2025
6-K Current report (foreign issuer) May 8, 2025 May 8, 2025
6-K Current report (foreign issuer) Apr 22, 2025 Apr 22, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TAK (NYSE), TKPHF (OTC)
Headquarters
Tokyo, Japan
SEC filer status
Large accelerated filer
SEC CIK
1395064

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.